Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection

By Hammel J.M.   Elfeki S.K.   Kobayashi N.   Ito M.   Cai J.   Fearon D.T.   Graham F.L.   Fox I.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 939-939

Elsevier

Access to resources Recommend Favorite

Human complement receptor type 1 (CR1) binds to a major malarial adhesin

By Krych-Goldberg M.   Moulds J.M.   Atkinson J.P.  

Trends in Molecular Medicine, Vol. 8, Iss. 11, 2002-11 ,pp. : 531-537

Elsevier

Access to resources Recommend Favorite

B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency

By Bax Hannelore   Freeman Alexandra   Anderson Victoria   Vesterhus Per   Laerum Dan   Pittaluga Stefania   Wilson Wyndham   Holland Steven  

Journal of Clinical Immunology, Vol. 33, Iss. 6, 2013-08 ,pp. : 1062-1066

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of hyperacute rejection by phosphatidylinositol-anchored mini-complement receptor type 1

By Mikata S.   Miyagawa S.   Yoshitatsu M.   Ikawa M.   Okabe M.   Matsuda H.   Shirakura R.  

Transplant Immunology, Vol. 6, Iss. 2, 1998-06 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients

By Gerenčer M.   Burek V.   Crowe B.A.   Barrett N.P.   Dorner F.  

Microbial Pathogenesis, Vol. 25, Iss. 5, 1998-11 ,pp. : 253-266

Academic Press

Access to resources Recommend Favorite